Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgad722 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Shuhuang Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Thyroid Research Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Training Program of Science and Technology Innovation Cultivation Special Fund.
Abstract (Originalsprache)
Context
The clinical relevance of the well-known association between thyroid cancer (TC) and breast cancer (BC) remains to be further defined.
Objective
This work aimed to investigate the effect of history of BC on the prognosis of TC.
Methods
This was a comparative cohort study of tumor behaviors and TC-specific mortality in 5598 patients with papillary thyroid cancer (PTC) and 604 patients with follicular thyroid cancer (FTC), all with a history of BC (TC-BC patients), and their propensity score–matched TC patients without a history of BC (TCnoBC patients) in Surveillance, Epidemiology and End Results (SEER) 18. The main outcome measure was TC-specific mortality.
Results
Lower TC distant metastasis rates of 2.4% vs 3.0% in PTC and 6.1% vs 9.1% in FTC and TC-specific mortality rates of 1.3% vs 2.6% in PTC and 5.8% vs 8.4% in FTC were found in TC-BC patients vs matched TCnoBC patients (all P < .05). Comparing TC-BC patients with matched TCnoBC patients, hazard ratios (HRs) for mortality were 0.472 (95% CI, 0.370-0.601) in PTC and 0.656 (95% CI, 0.461-0.934) in FTC (all P < .05). Such HRs for mortality in PTC were 0.397 (95% CI, 0.268-0.588; P < .001) when TC occurred before BC vs 0.607 (95% CI, 0.445-0.827; P = .002) when BC occurred before TC.
Conclusion
This study demonstrates a robust protective effect of a history of BC on TC-specific patient survival, which has strong implications for more precise prognostication of TC in such patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thyroid Research Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
ORCID-Profile: Mingzhao Xing
Förderung
- Guangdong Training Program of Science and Technology Innovation Cultivation Special Fund
Zitieren
APA
Lin, S., Wang, Z., & Xing, M. (2024). Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad722
Vancouver
Lin S, Wang Z, Xing M. Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad722
BibTeX
@article{Lin2024,
author = {Lin, Shuhuang and Wang, Zhuo and Xing, Mingzhao},
title = {Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgad722}
}
EUVIMED